At a glance
- Originator Pharmacia Corporation
- Class Antithrombotics; Small molecules
- Mechanism of Action Thromboxane A2 receptor antagonists; Thromboxane synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 09 Feb 1998 No-Development-Reported for Thrombosis in Italy (Unknown route)
- 17 May 1995 New profile